Liabilities / Assets
38th percentile
Higher debt load relative to assets than 38% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
38th percentile
Higher debt load relative to assets than 38% of similar nonprofits.
Liabilities / Revenue
63rd percentile
Higher debt load relative to revenue than 63% of similar nonprofits.
Net Margin
14th percentile
Higher net margin than 14% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
46th percentile
Faster asset growth than 46% of similar nonprofits.
Revenue Growth
2nd percentile
Faster revenue growth than 2% of similar nonprofits.
Assets
Up$5,479,080
Up $146,626 (+2.7%) from 2016
Net Assets
Down$5,042,106
Down $220,412 (-4.2%) from 2016
Liabilities
Up$436,974
Up $367,038 (+525%) from 2016
Revenue
Down$1,421,079
Down $2,754,385 (-66%) from 2016
Expenses
Down$1,641,491
Down $2,524,218 (-61%) from 2016
Net Income
Down-$220,412
Down $230,167 (-2359%) from 2016
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Charley's fund's singular mission is to support the development of treatments and a cure for duchenne muscular dystrophy (dmd). We identify and direct funding to the most compelling research and treatment programs related to dmd and, (cont. On sch. O.)
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2017 • Form 990Summary only. Only limited summary data is available for this year.